Breaking News, Collaborations & Alliances

Ori Biotech and CellGenix Collaborate

Promote innovation within closed-system cell and gene therapy manufacturing.

By: Contract Pharma

Contract Pharma Staff

Ori Biotech Ltd, an innovator in cell and gene therapy (CGT) manufacturing, and CellGenix GmbH, a global supplier of raw and ancillary materials for CGT and regenerative medicine, have announced a non-exclusive strategic partnership to achieve closed-system preparation, formulation and addition of CellGenix media and growth factors within CGT manufacturing for users of the Ori platform.   The Ori platform enables therapy developers and contract manufacturers to achieve automated CGT manufacturin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters